AbbVie

-$0.20 (-0.17%) As of 2:09 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.

CEO
Richard A. Gonzalez
Employees
47,000
Headquarters
North Chicago, Illinois
Founded
2011

ABBV Key Statistics

Market Cap
207.67B
Price-Earnings Ratio
41.60
Dividend Yield
4.21
Average Volume
6.35M
High Today
$117.85
Low Today
$116.78
Open Price
$117.79
Volume
453.12K
52 Week High
$118.67
52 Week Low
$79.11

ABBV News

BenzingaJul 26

FDA Strikes Off Incyte's Retifanlimab Application In Anal Cancer - Incyte Genomics

AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA AbbVie Inc (NYSE: ABBV) and Eli Lilly And Co (NYSE: LLY) will have to keep waiting
MarketWatchJul 26

AbbVie Eye Drug AGN-190584 Meets Endpoints in Phase 3 Study

By Matt Grossman AbbVie Inc.'s AGN-190584 drug, a potential treatment for presbyopia, met the primary and secondary endpoints of a Phase 3 trial, the company s
MarketWatchJul 23

AbbVie Gets FDA OK for Pediatric Skin Infection Drug

By Kimberly Chin AbbVie Inc. received U.S. Food and Drug Administration approval for its treatment of acute bacterial skin and skin structure infections in chi

ABBV Earnings

$0.00
$1.03
$2.06
$3.09
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$3.09 per share
Actual
Available Jul 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure